PortfoliosLab logo
PHG vs. PFE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between PHG and PFE is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

PHG vs. PFE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Koninklijke Philips N.V. (PHG) and Pfizer Inc. (PFE). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

PHG:

-0.20

PFE:

-0.50

Sortino Ratio

PHG:

0.05

PFE:

-0.54

Omega Ratio

PHG:

1.01

PFE:

0.94

Calmar Ratio

PHG:

-0.09

PFE:

-0.20

Martin Ratio

PHG:

-0.32

PFE:

-0.86

Ulcer Index

PHG:

15.96%

PFE:

13.36%

Daily Std Dev

PHG:

35.63%

PFE:

24.13%

Max Drawdown

PHG:

-79.52%

PFE:

-58.96%

Current Drawdown

PHG:

-52.84%

PFE:

-55.27%

Fundamentals

Market Cap

PHG:

$23.16B

PFE:

$131.28B

EPS

PHG:

$0.29

PFE:

$1.38

PE Ratio

PHG:

86.34

PFE:

16.73

PEG Ratio

PHG:

0.36

PFE:

0.59

PS Ratio

PHG:

1.29

PFE:

2.10

PB Ratio

PHG:

1.67

PFE:

1.45

Total Revenue (TTM)

PHG:

$17.98B

PFE:

$62.46B

Gross Profit (TTM)

PHG:

$7.81B

PFE:

$42.09B

EBITDA (TTM)

PHG:

$1.64B

PFE:

$16.71B

Returns By Period

In the year-to-date period, PHG achieves a -1.11% return, which is significantly higher than PFE's -9.84% return. Over the past 10 years, PHG has outperformed PFE with an annualized return of 1.79%, while PFE has yielded a comparatively lower 0.79% annualized return.


PHG

YTD

-1.11%

1M

6.96%

6M

-5.37%

1Y

-6.85%

5Y*

-6.97%

10Y*

1.79%

PFE

YTD

-9.84%

1M

7.40%

6M

-8.84%

1Y

-12.05%

5Y*

-3.76%

10Y*

0.79%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

PHG vs. PFE — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PHG
The Risk-Adjusted Performance Rank of PHG is 4040
Overall Rank
The Sharpe Ratio Rank of PHG is 3939
Sharpe Ratio Rank
The Sortino Ratio Rank of PHG is 3737
Sortino Ratio Rank
The Omega Ratio Rank of PHG is 3737
Omega Ratio Rank
The Calmar Ratio Rank of PHG is 4444
Calmar Ratio Rank
The Martin Ratio Rank of PHG is 4343
Martin Ratio Rank

PFE
The Risk-Adjusted Performance Rank of PFE is 2626
Overall Rank
The Sharpe Ratio Rank of PFE is 2222
Sharpe Ratio Rank
The Sortino Ratio Rank of PFE is 2121
Sortino Ratio Rank
The Omega Ratio Rank of PFE is 2323
Omega Ratio Rank
The Calmar Ratio Rank of PFE is 3737
Calmar Ratio Rank
The Martin Ratio Rank of PFE is 2929
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

PHG vs. PFE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Koninklijke Philips N.V. (PHG) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current PHG Sharpe Ratio is -0.20, which is higher than the PFE Sharpe Ratio of -0.50. The chart below compares the historical Sharpe Ratios of PHG and PFE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

PHG vs. PFE - Dividend Comparison

PHG's dividend yield for the trailing twelve months is around 3.54%, less than PFE's 7.36% yield.


TTM20242023202220212020201920182017201620152014
PHG
Koninklijke Philips N.V.
3.54%0.00%0.00%6.95%3.03%1.87%2.17%3.11%2.52%3.18%3.94%4.17%
PFE
Pfizer Inc.
7.36%6.33%5.70%3.12%2.64%3.92%3.68%3.12%3.53%3.69%3.47%3.34%

Drawdowns

PHG vs. PFE - Drawdown Comparison

The maximum PHG drawdown since its inception was -79.52%, which is greater than PFE's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for PHG and PFE. For additional features, visit the drawdowns tool.


Loading data...

Volatility

PHG vs. PFE - Volatility Comparison

Koninklijke Philips N.V. (PHG) has a higher volatility of 9.12% compared to Pfizer Inc. (PFE) at 8.61%. This indicates that PHG's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

PHG vs. PFE - Financials Comparison

This section allows you to compare key financial metrics between Koninklijke Philips N.V. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


5.00B10.00B15.00B20.00B25.00B20212022202320242025
4.10B
13.72B
(PHG) Total Revenue
(PFE) Total Revenue
Values in USD except per share items

PHG vs. PFE - Profitability Comparison

The chart below illustrates the profitability comparison between Koninklijke Philips N.V. and Pfizer Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%80.0%20212022202320242025
45.1%
79.3%
(PHG) Gross Margin
(PFE) Gross Margin
PHG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Koninklijke Philips N.V. reported a gross profit of 1.85B and revenue of 4.10B. Therefore, the gross margin over that period was 45.1%.

PFE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a gross profit of 10.87B and revenue of 13.72B. Therefore, the gross margin over that period was 79.3%.

PHG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Koninklijke Philips N.V. reported an operating income of 155.00M and revenue of 4.10B, resulting in an operating margin of 3.8%.

PFE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported an operating income of 2.79B and revenue of 13.72B, resulting in an operating margin of 20.3%.

PHG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Koninklijke Philips N.V. reported a net income of 76.00M and revenue of 4.10B, resulting in a net margin of 1.9%.

PFE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a net income of 2.97B and revenue of 13.72B, resulting in a net margin of 21.6%.